Lilly gets a boost from new weight-loss pill data as it weighs speedier approval in US
By Maggie Fick and Mrinalika Roy VIENNA (Reuters) – Eli Lilly’s bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and the company reaffirmed that it was too soon to assume the drug will be part of a new U.S. speedy review program. Lilly’s shares rose …
Lilly gets a boost from new weight-loss pill data as it weighs speedier approval in US Read More »









